Here’s one more! 💛 Love this graphic: 🎨Color-coded ⚙️Mechanism of action 🗓️ Approval timeline 🔂 How to sequence therapy 🥊 That’s a lot of punch in 1 image! 👀 clinical-breast-cancer.com/article/S1526-… Clinical Breast Cancer

A study showing disparate utilization of breast conservation therapy for early-stage BC in privately insured, in the highest income quartile, and metropolitan institutions. UCLA CORE Lab UCLA Surgery #bcsm #disparities #CBCjournal sciencedirect.com/science/articl…

A comprehensive review on current and emerging treatment options for metaplastic breast cancer, discussing how contemporary research tools could spur marked advances in disease-specific understanding of this tumor type. #bcsm #CBCjournal Alexandra Thomas sciencedirect.com/science/articl…

Important work out now in Clinical Breast Cancer: Sara Sakowitz Arjun Verma SSB, MD, MBE & team investigate disparities in access to #BCT for early-stage #BreastCancer. #MedTwitter

Clinical Breast Cancer Sara Sakowitz Arjun Verma SSB, MD, MBE Read the full manuscript here: sciencedirect.com/science/articl… #MedTwitter #SurgicalOncology #NewPub

Check out this algorithm to perform oncofertility counseling in premenopausal women with breast cancer by Matteo Lambertini, MD PhD Maria Grazia Razeti Clinical Breast Cancer Read more on this important topic : Fertility Preservation for Young Women With Breast Cancer sciencedirect.com/science/articl… #bcsm #fertility

Many molecular targets are identified & validated in the treatment of TNBC including the (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway as seen below. Read more about targeted therapies in TNBC 👇 Nour Abuhadra Komal Jhaveri Nicholas Mai #bcsm sciencedirect.com/science/articl…

Use of a concurrent PPI with palbociclib tablets does not significantly reduce PFS in patients treated for HR+ HER2- MBC. Read more about this topic👇 Craig Vargo #bcsm #CBCjournal sciencedirect.com/science/articl…

Metaplastic Breast Cancer pCR rates after neoadjuvant therapy, are seen at rates of 0% to 10% in study series, lower than TNBC, NOS Read more about Metaplastic Breast Cancer: Current Understanding and Future Directions Clinical Breast Cancer Alexandra Thomas #bcsm sciencedirect.com/science/articl…

Active Surveillance of Atypical Ductal Hyperplasia showed 3.8% progression risk at 2 years. In the immediate excision group, 84.3% were benign, 14.1% upgraded to DCIS and 1.6% upgraded to IDC Read more 👇 Clinical Breast Cancer #bcsm sciencedirect.com/science/articl…

The ratio of positive lymph nodes had the highest association with Ki67, followed by molecular subtype, tumor stage & age. Read more about the best cut-off Points for Ki67 proliferation index in early BC. #bcsm Sepehr Khosravi sciencedirect.com/science/articl…

A study aims to capture clinical and surgical practice patterns of patients with deleterious mutations in PALB2, CHEK2 and ATM genes. Read more 👇 #bcsm Clinical Breast Cancer Maria Fencer sciencedirect.com/science/articl…

ICYMI: What's the relationship b/t economic hardship & symptom distress for breast cancer patients prior to initiation of treatment? Read Margaret Rosenzweig's recent study on economic hardship in breast cancer patients, in print Clinical Breast Cancer: #hapc #pallcareresearch #nursetwitter

Dry Heat Treatment (Fluidotherapy) added to complete decongestive therapy lead to reduced pain and edema severity in patients with breast cancer related lymphedema. Read more about study 👇 #bcsm #CBCjournal pubmed.ncbi.nlm.nih.gov/38565462/

The Importance of Naming Structural Racism as a Root Cause of Racial Inequities in Breast Cancer Outcomes👇 #bcsm #RacialDisparities #CBCjournal Sydney Habert, MD clinical-breast-cancer.com/article/S1526-…

Study 🚨highlighting an opportunity to identify candidates for axillary de-escalation, potentially reducing morbidity and tailoring treatment more closely to individual patient needs. Read 👇 #bcsm #CBCjournal Boston Breast Surgeon Samir Mitri clinical-breast-cancer.com/article/S1526-…

A phase I study of alpelisib + capecitabine in pts with MBC showed that combination is safe and well-tolerated oral regimen. Treatment responses were observed regardless of HR and PIK3CA status. Read more👇 #bcsm Yara Abdou Carey Anders Lisa Carey, MD, ScM, FASCO sciencedirect.com/science/articl…

Axillary involvement is linked to increased risk of distant metastasis, read more about metastatic mechanisms sciencedirect.com/science/articl… Figure👇 illustrates the intricate mechanisms of programming the SLN microenvironment to become a metastatic niche. Professor Kefah Mokbel The Princess Grace Hospital #bcsm